Pathology

USA Health Launches In-House Molecular Cancer Tests For Precision Medicine

USA Health Launches In-House Molecular Cancer Tests For Precision Medicine

November 19, 2021
In

USA Health now offers two in-house molecular oncology tests—BRAF Gene Mutation Assay and Microsatellite Instability (MSI) Assay—for cancer patients. Onsite testing means patients receive results quicker and can start treatment sooner. The Molecular Pathology Laboratory at USA Health is the first precision oncology lab in the area. Previously, USA Health sent specimens to outside reference…

Ready to Subscribe?

Get weekly updates delivered right to your inbox.